Sitravatinib, Tislelizumab, Sitravatinib clinical trials

Phase II, Open-Label Study of preliminary efficacy of Sitravatinib in Combination with Tislelizumab in Patients with Metastatic Uveal Melanoma with liver metastases.

This study is looking at a new combination of medicines, Sitravatinib and Tislelizumab, for people with a type of eye cancer called uveal melanoma that has spread to the liver. We want to see how well this combination shrinks the cancer.